Try our Advanced Search for more refined results
Life Sciences - November, 2015
294 articles
- Blank Rome DQed From Boston Scientific Kickback Suit
- Dow Can't Dodge $456M Award In Patent Row, Bayer Says
- Thermo Fisher Wins Sanctions Bid In PE Group's Fraud Suit
- Amgen Seeks 1st Biosimilar Of Mega-Blockbuster Humira
- Fla. Pharmacy Recalls Vitamins For 'Severe' Vitamin D Risks
- Teva Launches $6.75B Offering To Back Allergan, Rimsa Deals
- Allergan, NY End Antitrust Fight Over Dementia Drug
- Montel-Endorsed Apparel Co. Scammed Consumers, FTC Says
- Sheppard Mullin Snags Snell & Wilmer Deal-Maker In LA
- Actavis Says Travelers Owes Defense In Opioid Abuse Suits
- Kirkland Steers Teva In Japanese Generics Venture
- Justices Reject Biolitec's $70M Contempt Appeal
- IRS Calls Mylan Patent Deal A 'License' In $100M Tax Fight
- High Court Won't Hear $176M Covidien Prior Art Appeal
- Life Sciences MVP: Sterne Kessler's Eldora Ellison
- A New Paradigm For Prescription Drug Labeling?
- MedTel Found In Contempt Again In Heart Monitor IP Fight
- Pozen Fires Back At Bass Group's Vimovo IPR Petition
- P&G Says Fixodent Users' Appeal Is Backed By Bad Evidence
- Teikoku Loses Bid To Boot 12 Firms From Lidoderm MDL
- Bio-Rad Will Ask 9th Circ. To Nix Whistleblower GC's Claims
- Medicines Co. Asks Fed. Circ. To Reopen IP Fight With Mylan
- Wright Hit With $11M Jury Verdict In Hip Implant Bellwether
- Herbalife KOs Pyramid Scheme Suit In Latest Round
- WuXi PharmaTech Shareholders OK $3.3B Go-Private Deal
- Kimberly-Clark Says Rival Recycling Arguments In Diaper Spat
- Dr. Reddy's Denied Stay In AstraZeneca Purple Pill Row
- Bass Takes Aim At Citius Drug Patent Under His Own Name
- WTO Dispute Roundup: Members Clash Over Ag, E-Payments
- Ore. Gets Suit Over J&J's Motrin 'Phantom Recall' Revived
- OPINION: In Search Of Our Best Law Firm Selves
- Convicted Ex-BNY Employee Settles SEC Insider Trading Case
- AstraZeneca's Cancer Drug Suit In Wrong Venue, Mylan Says
- An In-House Cheat Sheet On Tax Inversion Deals
- Deals Rumor Mill: Bain Capital, Syngenta, Deutsche Wohnen
- Life Sciences MVP: Paul Weiss' Nicholas Groombridge
- A Closer Look At Fed. Circ.'s Ruling In ClearCorrect
- Chicago Improves Opioid Case With Details About Doctors
- Life Sciences MVP: Latham & Watkins' Charles Ruck
- NJ High Court To Review Reversal Of $25M Accutane Verdict
- Shire Blocks Par From Selling Adderall Generic
- GOP Sens. Back Generic-Drug Imports As Prices Soar
- FDA Warning Wire: Suspect Records At Sandoz, Dr. Reddy's
- The 3 Biggest Myths About Tax Inversion Deals
- Consumers Say Claims Against Homeopathics Are Supported
- Bayer Can't Duck All Claims In Mirena IUD Lawsuit
- Eli Lilly Can't Escape Darvocet Suits While JPML Mulls Remand
- Dechert Nabs Energy, Pharma Deals Pro In London
- New Federal Rules Acknowledge It's Time To Drop The 'E'
- Bayer Urges Fed. Circ. To Nix $6M Award To Dow In IP Row
- Health, Life Sciences Cos. Have Most IP Theft Issues: Report
- 2015: A Blockbuster Year In Health, Life Sciences M&A
- Patients Urge 1st Circ. To Revive Sanofi Drug Dispute
- Antitrust Concerns Won't Derail $160B Pfizer-Allergan Deal
- The 7 Firms Behind The Mammoth Pfizer-Allergan Merger
- Botox Buyer Rips Allergan's Bid To Slip Price-Fixing Suit
- Cymbalta Users Appeal To 9th Circ. In Withdrawal Suit
- Record Inversion Deal Shows Pfizer Unfazed By New Rules
- Sanofi Says K&L Gates, Rival Stalling Sanctions In FCA Suit
- Pharma Cos. Say Chicago's Opioid Suit Lacks Specifics
- IP Firm Merchant & Gould Adds Life Sciences Pro In DC
- Life Sciences MVP: Kirkland & Ellis' Jay Lefkowitz
- Medical Device Maker Gets $7.5M From Jury In Contract Suit
- Prestige Inks $225M Deal With PE Firm For DenTek Oral Care
- Class Counsel Fees Getting 'Intense Judicial Scrutiny'
- Pfizer, Allergan To Merge In $160B Deal
- Eli Lilly Brazil Unit Not Covered In Tort Suits, Insurer Says
- Mylan, Perrigo Settle Suit After $27B Hostile Takeover Row
- Accident Victim Looks To Keep Pain Meds Out Of GM MDL Trial
- Heller Ehrman Slips $100M IP Malpractice Suit In 9th Circ.
- Albertsons Sold Unapproved ADHD Generic Drug, Parent Says
- GSK Loses Bid To Nix Experts Of Reed Smith Atty's Widow
- Novartis Faces Strict Pharmacy Oversight In $390M Deal
- Shareholder Suit Another Bitter Pill For GNC After Ore. Action
- New IRS Crackdown Not Enough To Halt Inversion Deals
- Deals Rumor Mill: Pfizer, 1MDB, Diebold
- Cancer-Drug Maker's FDA Data Incited Stock Drop, Suits Say
- Life Sciences MVP: Kirkland & Ellis' Jim Hurst
- Mylan, Ranbaxy Urge Stay Of Provigil Pay-For-Delay Suits
- Horizon Withdraws Depomed Bid After Blow In Calif. Court
- 3 Ways Technology Is Changing Law Office Designs
- Mirowski Blasts $6M Atty Fee Bill In Medtronic Patent Suit
- Hi-Tech Fails To DQ FTC's Trial Team In Labeling Row
- Ex-Stryker Salesman Can't Duck Employee Poaching Claims
- 13 Key Business Objectives For Corporate Legal Departments
- Life Sciences MVP: Irell's David Gindler
- Deals Rumor Mill: Pfizer, Cosco Group, Towers Watson
- IRS Announces Fresh Crackdown On Inversion Deals
- Pacira Escapes Shareholder Suit Over Drug Marketing
- J&J, Conn. Woman Spar Over 'Natural' Baby Wash Labels
- Judge Greenlights False Ad Suit Over Gingko Biloba
- Dr. Reddy's Sues To Use Purple Pill For Heartburn Generic
- FTC Gives Final OK To Endo's $8B Par Pharmaceutical Buy
- Charges Against Supplement Execs Can Boost Plaintiffs Attys
- Wright Parent Slips Metal Hip Bellwether As Case Goes To Jury
- NJ Patent Trial Witnesses Recount Drug-Making Challenges
- Fed. Circ. Won't Review PTAB's Decision In Bosch IP Case
- Pa. Risperdal Trial Paused Over Data Analysis Dispute
- Wis. Tribe Sues Feds Over Destroyed Hemp Crop
- Sandoz Submits Third Biosimilar Application To FDA
- Drugmakers Can't Appeal Remand of Darvocet Suits: 6th Circ.
- Bass AIA Challenge To Celgene Cancer Drug Patent Rejected
- Labaton Sucharow To Co-Head Biogen Investor Suit
- Full Fed. Circ. May Blunt On-Sale Bar's Risk To Small Cos.
- Dyax Investor Slams Shire's $5.9B Offer As Too Low
- NY Doc Gets Almost 4 Years In $100M Test-Referral Scheme
- OSI, Pfizer Say Breckenridge Infringed Cancer Drug Patents
- FTC, Profs Urge 3rd Circ. To Revive Pay-For-Delay Complaint
- BALCA Overturns Cert. Denial For Nuclear Medicine Job
- Allergan Slams Fed Preemption Claim In IPR Extortion Row
- Life Sciences MVP: Fish & Richardson's Jonathan Singer
- Federal, Calif. 'Slack-Fill' Laws Ensure Fill Of Litigation
- HIPAA Lessons From The Warner Chilcott Settlement
- FDA Warning Wire: Hangover Drinks, Compound Drugs, Fish
- Orthofix Wins 6th Circ. Appeal In Trade Secrets Row
- Houston Firm Loses Appeal Over Fen-Phen Referral Contract
- Feds Crack Down On Fraudulent Dietary Supplements
- Euro Pacific Fights Bid For Arbitration In $6M Contract Row
- CVS Says Precedent Supports Axing Vitamin E Labeling Suit
- FDA To Finalize Controversial Oversight Of Lab Tests In 2016
- Senate Questions Nominee FDA Chief's Pharma Ties
- Testing Strip Cos. Seek To Nix J&J Unit's Infringement Suit
- Buyers Say Supplement Co. Can't Block Pyramid Scheme Cert.
- Chamber Blasts New Bills Targeting Tax Inversions
- Warburg Pincus Backs New Pharma Co. With Hearty M&A Plans
- Suture Express Wants Liability Ruling In $200M Antitrust Suit
- Intuitive Board Fails To Dodge Claims Over Surgical System
- Fed. Circ. Limits Safe Harbor For Post-Approval Conduct
- J&J Dodges Baby Wash False Ad Class Action
- Boehringer, Teva Slam Aggrenox Buyers' Doc Production
- Surgical Co. Can't Nix Investor Suit Over Lens Implants
- Teva's Planned Generic Aloxi Infringes Helsinn IP, Judge Says
- Diabetes Drug MDL Ruling Helps Branded Cos. In Label Fights
- FDA Urged To Block Sales Of OTC Congestion Drug
- Industry Groups Back J&J Bid To Nix $140M Motrin Verdict
- Taylor-Wharton Unsecured Creditors Attack Key Worker Deal
- New Fla. Medical Pot Bill Revamps Distribution System
- Fed. Circ. Faults PTAB's Order Upholding Verinata Patent
- Supreme Court Won't Tackle $29M Suture Patent Award
- Merck Sales Reps Seek OK To Send Sex Bias Suit Notices
- High Court Passes On Biotech Co. Patent Licensing Fight
- Actavis Wants Courtroom Sealed In Anti-Seizure Drug Trial
- Hi-Tech Blasts FTC For Accessing Imprisoned CEO's Email
- Interference Appeals Not Just For Fed. Circ., Justices Told
- Loestrin Pay-For-Delay Suit Lacks Hard Data, 1st Circ. Told
- House Panel Can't Nix SEC Subpoena In Insider Trading Probe
- Caris Says Chancery Wrongly Backed Workers' Stock Claims
- How Recent Pro-Preemption Wave May Lift Brand-Name Drugs
- Husch Blackwell Adds Ex-Brinks Gilson Atty To Chicago Office
- Should In-House Counsel Use US Contract Terms In Europe?
- Privileged Docs In Adderall Pay-For-Delay Suit Still Off-Limits
- J&J Can't Pare Tylenol Liver Damage Bellwether: Pa. Judge
- Full Fed. Circ. To Review On-Sale Bar In Angiomax Patent Suit
- NY Wholesaler Joins Fray With GSK, Teva Conspiracy Suit
- FDA Orders Recall Of 2,800 Endoscope Cleaning Devices
- Texas Tort Reforms Don't Bar Medical Device Claims
- Wyeth Rejects Claim That It Promoted Off-Label Prescribing
- Sanofi-Aventis Says K&L Gates Can Be Sanctioned In FCA Suit
- Fed. Circ. Incentivizes Offshore Generic Drug Testing
- Take Your Marks: An Associate's Guide To Your 1st Big Trial
- Ex-Pharma Exec Says Indictment Too Thin To Prep Defense
- Mylan Loses Monthslong Perrigo Takeover Battle
- Pfizer, Endo Unit Duck MDL Claims Over Testosterone Drugs
- Express Scripts Sues Horizon For $140M, Cuts Pharmacy Ties
- Pfizer Unit Slams Retailers' Skelaxin Pay-For-Delay Claims
- Procter & Gamble, Rite Aid Again Escape Fixodent Mass Tort
- Supplement Co. Claims Rival Uses Unapproved Drugs
- Fed. Circ. Affirms Hospira Win In Generic Cubicin Patent Suit
- Zimmer's Expert Takedown Poses Hurdles For Knee Patients
- J&J Can't Move Pelvic Mesh Cases Out Of Philly
- 3rd Circ. Asked To Revive Effexor Pay-For-Delay Claims
- Revived Genaera Shareholder Suit Gets Nixed Again
- AstraZeneca Prices $6B Bond To Help Fund ZS Pharma Buy
- Invitation To Clarify How Plaintiffs Prove Class Membership
- J&J Unit Settles Proposed Bellwether In Vaginal Mesh MDL
- Ex-BNY Manager Gets 6 Months For Insider Trading
- Pomerantz Named Lead Counsel In $121M ConforMIS IPO Suit
- Merck's $17B Takeover Of Sigma-Aldrich Gets EU's Final OK
- Endo Has No Privilege To Withold SEC Drafts In Drug MDL
- Valeant Can't Dodge Insider Trading Row Over Allergan Bid
- FDA Warning Wire: Dr. Reddy's, DNA4Life, Cholesterol Pills
- ClearCorrect Ruling Keeps ITC From Policing Web Piracy
- GNC Hit With Suit Over Alleged Illegal Ingredients
- Iovate Settles Spiked Protein Accusations For $2.5M
- Fed. Circ. Revives 1 Of 2 Lovenox Patent Suits
- Calif. City Sues Monsanto, Pfizer Unit For PCB Contamination
- Valeant Workers 'Pissed' About Bogus Allegations, CEO Says
- Seeger Weiss Dodges Widow's Suit Over Vioxx Settlement
- Lawmaker Targets Inversions As Pfizer Mulls Allergan Deal
- Gatorade Owner Drops Trademark Suit Over 'Haterade'
- 3 Pressing Challenges For Personalized Medicine
- ITC Can't Block Infringing Digital Files, Fed. Circ. Says
- Sanofi Faces Contract Suit Over $708M In MS Drug Payments
- Merck, Others Beat Warning Claims In Diabetes Drug MDL
- Herbalife Investors Say Third Time's Charm For Pyramid Suit
- Texas Pelvic Mesh Ruling Could Make Plaintiffs Think Twice
- Arthrex Asks High Court To Review Part Of $95M Patent Loss
- Inside Mylan's Pursuit Of Perrigo
- J&J, Covidien Settle Injunction Spat In Patent Row
- Ethicon Says Mesh Patients Abusing Discovery In MDL
- 3 Key Issues To Watch As Pricing Probes Swamp Big Pharma
- HFF Brokers $96.4M Loan For Calif. Biotech Campus Project
- Watchdog Finds Doping On Russian Athletics Team
- Former Top Advisor, Attorney At FDA Joins Covington in DC
- Abbott Wins Injunction On 'Gray Market' Diabetes Test Strips
- Columbia Dismissed From Bard Pelvic Mesh Coverage Suit
- High Court Asked To Review Standing In Prosthetic IP Row
- German Insurer Says Baxter Docs Not Privileged Under Ill. Law
- J&J Hit With $1.75M Verdict In 4th Philly Risperdal Case
- Justices Refuse Bids To Stop Apotex's Benicar Patent Suit
- The Evolution Of Federal Policy On Human Test Subjects
- 8 Ways Trans-Pacific Partnership Affects Patent Rights
- 3rd Quarter Saw A Rise In FCPA Enforcement
- Did Fed. Circ. Doom The New Biosimilar Approval Pathway?
- Law360's Super MVPs In A Class Of Their Own
- 5 Firms Lead The Pack With MVP Wins
- Law360 MVP Awards Go To Legal Aces From 86 Firms
- High Court Urged To Weigh In On Drug 'Product-Hopping'
- Bayer Sued Over Sterilization Device Essure's Side Effects
- AstraZeneca Blocks Dr. Reddy's Purple Heartburn Pills
- Covidien Urges Justices To Tackle 'Secret Prior Art'
- Provigil Judge Says Experts Can Testify On Patent Strength
- FDA Panel Says Certain Antibiotic Warnings Are Inadequate
- WTO Panel Inks 17-Year Drug Patent Waiver For Poor Nations
- Novartis Sues Amneal, Dr. Reddy's Over Dementia Patches
- 113 Seek Mass Tort In Pa. Over Birth Control Packaging
- Goldman Cashes In Valeant Shares Backing CEO's $100M Debt
- AstraZeneca Inks $2.7B Deal For ZS Pharma
- Taxation With Representation: Fenwick, Ropes, Wachtell
- Hagens Berman Defends Bid to Nix Sanctions At 3rd Circ.
- 5th Circ. Will Rehear Stryker Toe Implant Fight
- Jury Clears Zimmer Of Design Defect In 1st Knee Implant Trial
- Texas Court Kills $1.2M Pelvic Mesh Verdict Against J&J
- Sen. Hatch Says Drug IP Provisions May Doom TPP
- Apotex Wants Lupin Docs In Patent Suit Jurisdiction Row
- PhRMA Backs Merck In 3rd Circ. Over Nixed Fosamax Claims
- FDA Cracks Down On The Dietary Supplement Industry
- Chicago Looks To Revive Dismissed Opioid Conspiracy Suit
- Union Funds Ask Del. High Court To Reinstate False Ad Suit
- All You Need To Know About The Trans-Pacific Partnership
- Teikoku Backs Up Bid To DQ 12 Firms In Lidoderm MDL
- TPP Aims To Spread US-Style IP Protections Overseas
- TPP Leaves Leeway On Biologics Exclusivity
- Jury Deliberating In 1st Zimmer Knee Implant Bellwether
- Ethicon Stapler Suit Belongs Outside US, 6th Circ. Told
- States Are Taking Charge Of Antibiotic Use In Animals
- Pa. Court Axes $1.7M Award In Wyeth Water Treatment Row
- Sex Supplement Suit Not Barred By Federal Law, Judge Says
- Hi-Tech Evades Contempt Finding In FTC Suit For Now
- J&J Can't Dodge Costco Antitrust Claims Over Pricing Policy
- 11th Circ. Urged To Keep Diagnostic Co. Owner's $6M Verdict
- AstraZeneca, Teva Unit Finalize $54M Deal In Medicaid Row
- Bayer Owes MDL Attys $9M For GMO Deal, 8th Circ. Told
- DOJ, SEC Probing Alexion Over FCPA Compliance
- High Court Urged To Review $70M Biolitec Contempt Ruling
- AstraZeneca Wields Amarin Win In FDA Exclusivity Fight
- More Wright Hip Implant Evidence Filtered By Ga. Judge
- OPINION: Via Duke, Companies Are Shaping Discovery
- Med Device Biz To Go Private In $812M Citic Deal
- France Launches Criminal Probe Tied To IAAF Doping Claims
- REMS Abuse And Antitrust Injury: Round Peg, Square Hole
- FTC Names Pay-For-Delay Czar To Interim Antitrust Post
- Atty Knocks Supplement Maker's Sanctions Bid In 3rd Circ.
- Citron's Left Can't Halt HK Case Over Evergrande Report
- Mintz Levin Adds Biopharma IP Member In DC
- FDA Warning Wire: Pfizer's Suspicious Pharma Tests
- Jones Day Adds Former Robbins Geller IP Pro In Atlanta
- Enzo, Applera Spar Over Fate Of DNA-Test Patent Verdict
- AstraZeneca Hits Mylan With Patent Suit Over Blood Thinner
- Mylan Must Sell 7 Generic Drugs Ahead Of Perrigo Deal: FTC
- DOJ Taps Ex-Standard Chartered Bribery Cop For New Role
- Ariosa V. Sequenom Signals Trouble Ahead For Life Sciences
- Strategies For Law Firms Leaping Into Latin America
- Inequitable Conduct Behind Regeneron Patent, Judge Finds
- 2nd Circ. Asked To Uphold Pregnancy Test Recall
- Venture Fund Says PwC Failed To Catch $17M Fraud
- Major Cos., IP Groups Call For Clearer USPTO Alice Rules
- BCBS Fights Dismissal Bid In Aggrenox Pay-For-Delay Suit
- Abbott, AbbVie Win Over Jury In Depakote Birth Defect Row
- 3 Key Questions As Biosimilar Naming Fight Rages On
- HHS Inspector General Details 2016 Investigative Plans
- Evidence Trimmed In Wright Hip Implant Bellwether Case
- Hospira Investor Seeks Stock Appraisal Of $17B Pfizer Deal
- 4 Life Science Cos. Set Terms For IPOs Totaling $276M
- Noven Sues To Block Mylan's Generic ADHD Patch
- Dueling Opinions Tee Up Appeal Over Pa. Risperdal Punitives
- Bristol-Myers Pays $2.1B For Heart Failure Drug Co.
- Blue Shield Faces Suit In Calif. Over Hep C Drug Denials
- Ethicon Blocking Witnesses In Pelvic Mesh MDL, Victims Say
- Simpson Thacher Steers Pamplona On $2.7B MedAssets Deal
- Ropes & Gray Steers Shire To $5.9B Deal For Dyax
- Authenticating Art With Bioengineered DNA: The IP Issues
- Using Information Graphics Effectively In The Courtroom
- 5 Takeaways From The Novartis FCA Settlement